The CiticOline Brain Injury Trial (COBRIT) has enrolled 1,213 patients with mild-to-severe TBI and assessed the effect of enteral or oral citicoline (2,000 mg/day, for 90 days) on functional and cognitive outcomes (measured by components of the TBI Clinical Trials Network Care Battery) (103)
Making decisions based on the current pricing landscape - while staying aware that it's subject to change - is a practical approach
In ALT responders, glutathione treatment decreased NEFA, ferritin, and HDL cholesterol levels but increased HbA1c levels
Additionally, recent studies have identified bacterial DNA in human and mouse adipose tissues 20,21
SeekPeptides has compiled the most comprehensive analysis of these two treatments available anywhere, incorporating data from multiple phase 3 trials, mechanistic studies, and the latest regulatory filings